Skip to main content
Fig. 1 | BMC Neurology

Fig. 1

From: In vitro examination of the thrombolytic efficacy of tenecteplase and therapeutic ultrasound compared to rt-PA

Fig. 1

Results from dose finding experiments with rt-PA: Weight loss measurements after 1 and 2 h of treatment with escalating dosages from 0 to 100 μg/ml rt-PA (n = 10 for every dosage) were performed to determine the maximum effective dosage for rt-PA. Bars reflect the standard deviation (SD) from the mean. For reasons of clarity, we omitted the SD of the control group (SD for 1 h: 5.7%; SD for 2 h: 7.4%)

Back to article page